News
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its eXpDNA™ plasmid platform, established from the Company’s contract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback